Search

Your search keyword '"Hogben K."' showing total 44 results

Search Constraints

Start Over You searched for: Author "Hogben K." Remove constraint Author: "Hogben K."
44 results on '"Hogben K."'

Search Results

2. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

Catalog

Books, media, physical & digital resources

3. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

5. A measure of case complexity for streamlining workflow in multidisciplinary tumor boards: Mixed methods development and early validation of the MeDiC tool.

6. A ‘best practice’ care pathway improves management of mastitis and breast abscess

7. The UK-PBC Risk Scores: Derivation and Validation of a Scoring System for Long-Term Prediction of End-Stage Liver Disease in Primary Biliary Cholangitis

9. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

11. The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis

12. Patient‐level costs in margin re‐excision for breast‐conserving surgery.

13. Best‐practice care pathway for improving management of mastitis and breast abscess.

14. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways

28. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

29. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways

30. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

31. Clinicopathological Predictors of Positive Resection Margins in Breast-Conserving Surgery.

33. Single-stage buried autologous breast reconstruction (BABR).

34. Patient-level costs of staged unilateral versus immediate bilateral symmetrization mammoplasty in breast-conserving surgery.

35. The feasibility and safety of immediate breast reconstruction in the COVID-19 era.

36. A measure of case complexity for streamlining workflow in multidisciplinary tumor boards: Mixed methods development and early validation of the MeDiC tool.

37. Can we see what is invisible? The role of MRI in the evaluation and management of patients with pathological nipple discharge.

38. Training the Trainers of Tomorrow Today - driving excellence in medical education.

39. Biological basis of [¹¹C]choline-positron emission tomography in patients with breast cancer: comparison with [¹⁸F]fluorothymidine positron emission tomography.

40. Management and outcome of HER2-positive early breast cancer treated with or without trastuzumab in the adjuvant trastuzumab era.

42. Schizophrenia does not adversely affect the treatment of women with breast cancer: a cohort study.

43. The role of SRC-3 in human breast cancer.

44. [11C]choline positron emission tomography in estrogen receptor-positive breast cancer.